Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Mitochondrial rewiring may explain why orthoflaviviruses harm humans but persist in mosquitoes

12

Aug 2026

Mitochondrial rewiring may explain why orthoflaviviruses harm humans but persist in mosquitoes

Orthoflaviviruses reshape mitochondrial structure, metabolism, redox signaling, and quality control differently across human and mosquito models, helping explain their contrasting infection outcomes. The review highlights mitochondrial pathways that may support acute cellular damage in vertebrates but persistent, non-lethal infection in mosquitoes, pointing to potential antiviral targets.

Social media isn’t simply good or bad for young people, and this review shows why

12

Aug 2026

Social media isn’t simply good or bad for young people, and this review shows why

Social media can support connection, self-expression, help-seeking, and community among adolescents and young adults, but problematic use is associated with depression, anxiety, loneliness, poor sleep, and body image concerns. The review finds that mental health effects depend less on screen time alone than on how social media is used, what content people encounter, and their individual, developmental, and cultural context.

AI took on doctors in simulated video consultations, and the results were striking

12

Aug 2026

AI took on doctors in simulated video consultations, and the results were striking

Google researchers developed AMIE, a Gemini-based multi-agent system combining real-time audio-visual perception, clinical reasoning, and low-latency dialogue for simulated video consultations. In a randomized OSCE across 100 clinical scenarios, AMIE Video matched or exceeded primary care physicians across core clinical measures, while patient actors preferred video over text, although real-world clinical validation is still needed.

Inhaled cannabis reduces premature heartbeats in habitual users

12

Aug 2026

Inhaled cannabis reduces premature heartbeats in habitual users

Habitual cannabis users experienced about 9% fewer premature heartbeats on days they inhaled cannabis compared with days they abstained, a counterintuitive finding that adds to the complex and evolving understanding of how cannabis affects the heart, new UC San Francisco-led research found.

Pregnant women use Reddit to seek Tdap vaccine reassurance

12

Aug 2026

Pregnant women use Reddit to seek Tdap vaccine reassurance

An analysis of Reddit posts about the maternal Tdap vaccine made by pregnant women reveals expectant mothers turning to Reddit to seek advice and reassurance-with fewer outright instances of vaccine hesitation/refusal than has generally been observed for other types of vaccines, according to a study published on August 12, 2026 in the open access journal PLOS Global Public Health by Soojung Jo from Purdue University, United States, and colleagues.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.